Pablo Legorreta

Pablo Legorreta

Pablo Legorreta (#970)

  • $ 4 B
  • Investments
  • United States
  • M
  • 62 Years

About Me

Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams. Royalty Pharma, which conducted an IPO in 2020, has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi. A former investment banker at Lazard Fr'res, Legoretta started Royalty Pharma in New York as a private equity vehicle in 1996. In May 2025, Royalty Pharma acquired its external investment manager RP Management in a $1.1 billion deal. Legorreta owned 100% of RPM until 2024, when he gave just under half his stake to employees
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Pablo Legorreta’s rise and global influence.

  • #1044   Billionaires (2026)
  • #326   Forbes 400 (2024)

Wealth Growth

Net Worth Growth Over Time

Tracking Pablo Legorreta’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $4.4B (May 4, 2026)